Back
Corporate News
Transgene Biotek confirms Regulation 57 not applicable for quarter ending September 30, 2026
03-Oct-2026, 07:39
Transgene Biotek Limited informed the BSE Limited that Regulation 57 of SEBI’s (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the company for the quarter ended September 30, 2026, as there are no non-convertible securities for which interest, dividend, or principal is payable.
